Publications by authors named "Shau Yin Ha"

Article Synopsis
  • * Three new recurring KMT2A-rearranged groups were identified, and a significant variation in 5-year event-free survival rates was observed across 13 different groups, highlighting the impact of genetic factors on patient outcomes.
  • * The research suggests incorporating five specific adverse-risk KMT2A fusions into current risk stratification models and calls for further studies to confirm the associations
View Article and Find Full Text PDF

Introduction: Medulloblastoma is the most common malignant brain tumor in children, often requiring intensive multimodal therapy, including chemotherapy with alkylating agents. However, therapy-related complications, such as therapy-related myeloid neoplasms (t-MNs), can arise, particularly in patients with genetic predisposition syndromes. This case report presents three pediatric cases of medulloblastoma with subsequent development of t-MNs, highlighting the potential role of genetic predisposition and the importance of surveillance for hematological abnormalities in long-term survivors.

View Article and Find Full Text PDF

Introduction: Invasive fungal infections (IFI) cause significant mortality and morbidity in the Paediatric Intensive Care Unit (PICU). Early recognition and prompt treatment of invasive fungal infections are important. This article reviewed the mortality and morbidity of IFIs in the PICU of Hong Kong Children's Hospital.

View Article and Find Full Text PDF

Background: In onco-nephrology, data on acute kidney injury (AKI) among children with haematological malignancies are scarce.

Methods: A retrospective cohort study of all patients in Hong Kong diagnosed with haematological malignancies from 2019 to 2021 before 18 years of age, was conducted to investigate the epidemiology, risk factors and clinical outcomes of AKI during the first year of treatment. AKI was defined according to the Kidney Disease: Improving Global Outcomes (KDIGO) criteria.

View Article and Find Full Text PDF
Article Synopsis
  • A study by the I-BFM-SG on childhood rearranged acute myeloid leukemia (AML) revealed that the type of fusion partner plays a significant role in prognosis, and it also explored the effectiveness of flow cytometry-based measurable residual disease (flow-MRD) and allogeneic stem-cell transplantation (allo-SCT) in improving outcomes during first complete remission.
  • The research involved 1,130 children diagnosed with rearranged AML, who were categorized into high-risk and non-high-risk groups based on their fusion partners, and it focused on the relationship between flow-MRD levels and long-term survival rates.
  • Results showed that the high-risk group had significantly worse event-free survival, cumulative incidence of relapse, and overall survival
View Article and Find Full Text PDF

Hematopoietic stem cell transplant is potentially curative for relapsed/refractory leukemia. However, neurotoxicity is common and has been reported in 11% to 59% of children following hematopoietic stem cell transplant. Most pediatric studies of the neurological effects of hematopoietic stem cell transplant have focused on acute neurotoxicity.

View Article and Find Full Text PDF

Unlabelled: Despite the expanding portfolio of targeted therapies for adults with acute myeloid leukemia (AML), direct implementation in children is challenging due to inherent differences in underlying genetics. Here we established the pharmacologic profile of pediatric AML by screening myeloblast sensitivity to approved and investigational agents, revealing candidates of immediate clinical relevance. Drug responses ex vivo correlated with patient characteristics, exhibited age-specific alterations, and concorded with activities in xenograft models.

View Article and Find Full Text PDF

Thalassemia is one of the most common genetic diseases and a major health threat worldwide. Accurate, efficient, and scalable analysis of next-generation sequencing (NGS) data is much needed for its molecular diagnosis and carrier screening. We developed NGS4THAL, a bioinformatics analysis pipeline analyzing NGS data to detect pathogenic variants for thalassemia and other hemoglobinopathies.

View Article and Find Full Text PDF

As treatments for second relapsed and refractory first relapsed paediatric AML transition from purely palliative to more commonly curative in nature, comparative data is necessary for evaluating the effectiveness of emerging treatment options. Furthermore, little is known about predictors of prognosis following third-line therapy. From 2004 until 2019, 277 of the 869 patients enrolled in NOPHO-DB SHIP consortium trials experienced a first relapse and, of these patients, 98 experienced refractory first relapse and 59 a second relapse.

View Article and Find Full Text PDF

Background: We hypothesize that cardiac magnetic resonance (CMR) native T1 is associated with myocardial deformation in thalassaemia patients. The present study aimed to compare CMR native T1 values to conventional T2* values in patients with beta-thalassaemia and to explore relationships between these CMR parameters of myocardial iron overload and left ventricular (LV) and left atrial (LA) myocardial deformation.

Methods: Thirty-four (16 males) patients aged 35.

View Article and Find Full Text PDF

Asparaginase is an important drug to treat childhood haematological malignancies. Data on the association between human leukocyte antigens (HLA) and asparaginase hypersensitivity among Chinese are lacking. We conducted a retrospective study to identify HLA alleles associated with asparaginase hypersensitivity among Chinese children with acute lymphoblastic leukaemia (ALL), mixed phenotype leukaemia and non-Hodgkin lymphoma (NHL), who received asparaginases with HLA typing performed between 2009 and 2019.

View Article and Find Full Text PDF

Background: Hematopoietic stem cell transplantation, despite being a curative treatment for various pediatric disorders, is associated with significant acute and chronic complications.

Methods: This retrospective review of 196 hematopoietic stem cell transplantation episodes (144 allogeneic, 52 autologous) performed in a tertiary pediatric unit focused on neurological symptoms and complications occurred from the start of conditioning to within 3 years of transplantation. Indications for transplantation included both benign and malignant diseases.

View Article and Find Full Text PDF
Article Synopsis
  • Cytogenetic and molecular changes at the time of relapse significantly impact the prognosis of children with de novo acute myeloid leukemia (AML), though their role has been under-studied.
  • An international study reviewed data from 403 out of 569 pediatric AML patients to identify the prognostic value of cytogenetic profiles at relapse, finding that certain genetic aberrations correlated with better or worse outcomes.
  • The results suggest that assessing cytogenetic profiles at relapse is crucial for determining survival chances and could enhance personalized treatment strategies for young patients with relapsed AML.
View Article and Find Full Text PDF

Acute myeloid leukemia (AML) accounts for 15% to 20% of childhood leukemias. Because of high-intensive therapy, up to 5% of patients suffer from treatment-related mortality (TRM). Abdominal complications are frequent, however, literature on this subject is sparse.

View Article and Find Full Text PDF
Article Synopsis
  • Early death (ED) is a significant issue in acute promyelocytic leukemia (APL), occurring in 16% of newly diagnosed patients in a study conducted in Hong Kong from 2007 to 2020.
  • Factors linked to increased risk of ED include male sex, high leukocyte counts, low fibrinogen levels, and delayed administration of all-trans retinoic acid (ATRA) beyond 24 hours after admission.
  • The study highlighted that early ATRA treatment and addressing blood clotting issues are crucial for improving survival rates, with overall survival rates rising significantly when early deaths are excluded.
View Article and Find Full Text PDF

Allogeneic hematopoietic stem cell transplantation is curative for transfusion-dependent thalassemia, but mixed chimerism (MC) may herald graft rejection. We report a child who failed bone marrow transplant (BMT) from matched unrelated donor (MUD) successfully salvaged with haploidentical peripheral blood stem cell transplant (PBSCT), but had MC in T-lymphocyte compartment despite near-complete donor chimerism in myeloid compartment. MC was successfully improved by repeated CD45RA-depleted donor lymphocyte infusion (DLI).

View Article and Find Full Text PDF

Our patient was a 4-year-old female with acute myeloid leukemia complicated with right calcaneal osteomyelitis due to Mycobacterium abscessus with subcutaneous abscesses extending to the popliteal and groin regions after two courses of induction chemotherapy according to NOPHO-AML 2012 protocol. She required multiple operations and prolonged anti-mycobacterial therapy. A high index of suspicion for mycobacterial infection is required for immunocompromised patients with prolonged fever or unusual presentation.

View Article and Find Full Text PDF

Background: Associations between body mass index (BMI), outcome, and leukemia-related factors in children with acute myeloid leukemia (AML) remain unclear. We investigated associations between pretherapeutic BMI, cytogenetic abnormalities, and outcome in a large multinational cohort of children with AML.

Methods: We included patients, age 2-17 years, diagnosed with de novo AML from the five Nordic countries (2004-2016), Hong Kong (2007-2016), the Netherlands and Belgium (2010-2016), and Canada and USA (1995-2012).

View Article and Find Full Text PDF

Glucose phosphate isomerase (GPI) deficiency is the second most common red blood cell enzymopathy involving the glycolysis pathway. It is an autosomal recessive disorder. Chronic hemolytic anemia is a common manifestation.

View Article and Find Full Text PDF

This study aimed to assess left (LA) and right atrial (RA) function in patients with beta-thalassaemia major. Thirty-eight patients (19 males) aged 34.5 ± 10.

View Article and Find Full Text PDF
Article Synopsis
  • This study examines the use of granulocyte colony-stimulating factor (G-CSF) in pediatric patients with acute myeloid leukemia (AML) and its potential link to increased relapse risk.
  • G-CSF was administered to 35% of the 367 patients, with a noticeable decrease over time, indicating variability in use across different treatment centers.
  • Results suggested that G-CSF treatment is associated with a higher risk of relapse, with an adjusted hazard ratio of 1.5, raising concerns about its role in supportive care during AML treatment.
View Article and Find Full Text PDF

We report the first case of microabscesses detected by polymerase chain reaction (PCR) amplification of nucleic acid from ultrasound-guided aspirated fluid in a three-year old boy with acute lymphoblastic leukemia and febrile neutropenia during induction chemotherapy. Fever persisted despite effective antifungal treatment. The addition of corticosteroid therapy successfully controlled the suspected immune reconstitution inflammatory syndrome (IRIS).

View Article and Find Full Text PDF

Data on occurrence, genetic characteristics and prognostic impact of complex and monosomal karyotype (CK/MK) in children with acute myeloid leukaemia (AML) are scarce. We studied CK and MK in a large unselected cohort of childhood AML patients diagnosed and treated according to Nordic Society for Paediatric Haematology and Oncology (NOPHO)-AML protocols 1993-2015. In total, 800 patients with de novo AML were included.

View Article and Find Full Text PDF